We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.5B
AUM Growth
+$857M
Cap. Flow
+$670M
Cap. Flow %
14.88%
Top 10 Hldgs %
17.64%
Holding
512
New
198
Increased
109
Reduced
79
Closed
118

Sector Composition

Rank Sector Weight
1 Healthcare 13.99%
2 Industrials 12.65%
3 Financials 10.63%
4 Consumer Discretionary 9.16%
5 Energy 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGI
301
DELISTED
Triumph Group
TGI
$2.42M 0.05%
34,624
-292,966
-89% -$19.8M
PNNT
302
Pennant Park Investment Corp
PNNT
$242M
$2.32M 0.05%
+202,307
New +$2.22M
WFT
303
CALL
DELISTED
Weatherford International plc
WFT
$2.3M 0.05%
+100,000
New +$2.06M
ASC icon
304
Ardmore Shipping
ASC
$684M
$2.29M 0.05%
165,216
-135,285
-45% -$1.83M
ADPT
305
DELISTED
Adeptus Health Inc
ADPT
$2.24M 0.05%
+88,333
New +$2.25M
VTSS
306
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$2.23M 0.05%
+647,639
New +$2.38M
CMCM
307
Cheetah Mobile
CMCM
$96.5M
$2.12M 0.05%
+20,000
New +$1.79M
ITCI
308
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$2.12M 0.05%
125,493
-69,070
-36% -$1.14M
TSE
309
DELISTED
Trinseo
TSE
$2.1M 0.05%
+101,190
New +$2.17M
CLDX icon
310
Celldex Therapeutics
CLDX
$3.26B
$2.06M 0.05%
8,429
+5,096
+153% +$1.15M
TSRO
311
DELISTED
TESARO, Inc.
TSRO
$2.05M 0.05%
+65,928
New +$1.76M
RVNC
312
DELISTED
Revance Therapeutics, Inc.
RVNC
$2.04M 0.05%
+60,000
New +$1.88M
ARDX icon
313
Ardelyx
ARDX
$998M
$2.02M 0.04%
+126,191
New +$1.93M
JMEI
314
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$1.95M 0.04%
+7,180
New +$1.9M
CSLT
315
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.91M 0.04%
125,663
+24,520
+24% +$398K
FRAN
316
DELISTED
Francesca's Holdings Corporation
FRAN
$1.89M 0.04%
+10,658
New +$2.06M
KITE
317
DELISTED
Kite Pharma, Inc.
KITE
$1.82M 0.04%
+63,095
New +$1.88M
GLOP
318
DELISTED
GASLOG PARTNERS LP
GLOP
$1.8M 0.04%
+49,598
New +$1.46M
SFLY
319
DELISTED
Shutterfly, Inc.
SFLY
$1.78M 0.04%
+41,326
New +$1.69M
OAKS
320
DELISTED
Five Oaks Investment Corp.
OAKS
$1.7M 0.04%
+150,500
New +$1.76M
SPWR
321
DELISTED
SunPower Corporation Common Stock
SPWR
$1.64M 0.04%
+61,080
New +$1.34M
OPWR
322
DELISTED
OPOWER INC COM STK (DE)
OPWR
$1.63M 0.04%
+86,461
New +$1.61M
RXII
323
CALL
DELISTED
GALENA BIOPHARMA INC COM
RXII
$1.62M 0.04%
530,000
WWAV
324
CALL
DELISTED
The WhiteWave Foods Company
WWAV
$1.62M 0.04%
+50,000
New +$1.5M
EXL
325
DELISTED
EXCEL TRUST , INC COM STK
EXL
$1.6M 0.04%
+120,349
New +$1.56M

Similar funds

Alyeska Investment Group's Q2 2014 Portfolio in Review

As of Q2 2014, Alyeska Investment Group held 512 positions worth $4.5B, up 24% from $3.64B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $670M of net new capital in Q2 2014, opening 198 new positions and adding to 109 existing holdings. Its largest new stake was Amsurg Corp: 1,600,000 shares worth $72.9M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Pinnacle Foods, Inc., an estimated $34.3M trimmed.

  • Alyeska Investment Group's largest Q2 2014 buy was Amsurg Corp: 1,600,000 shares worth $72.9M.
  • Alyeska Investment Group added most to Capital One in Q2 2014, an estimated $18.5M increase.
  • Alyeska Investment Group's biggest Q2 2014 reduction was Pinnacle Foods, Inc., cutting an estimated $34.3M.
  • Alyeska Investment Group fully exited Pfizer in Q2 2014, selling an estimated $32.3M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.5B portfolio in Q2 2014.
  • Alyeska Investment Group opened 198 new positions and closed 118 in Q2 2014.
  • Alyeska Investment Group's portfolio value rose 24% quarter-over-quarter to $4.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2014, filed 14 Aug 2014.